These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21724730)

  • 21. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab.
    Filippucci E; Iagnocco A; Salaffi F; Cerioni A; Valesini G; Grassi W
    Ann Rheum Dis; 2006 Nov; 65(11):1433-7. PubMed ID: 16504996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis.
    Kageyama Y; Kobayashi H; Kato N; Shimazu M
    Mod Rheumatol; 2009; 19(4):372-8. PubMed ID: 19458908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of combination therapy and nonsteroidal antirheumatic agents on acute phase reactants in patients with rheumatoid arthritis].
    Berdnik-Gortan K; Bjelinski D
    Reumatizam; 1999; 46(1):12-6. PubMed ID: 11552614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary abnormalities in patients with early and longstanding rheumatoid arthritis.
    Georgiadis AN; Metafratzi ZM; Drosos AA
    J Rheumatol; 2009 Feb; 36(2):444-5; author reply 445-6. PubMed ID: 19208573
    [No Abstract]   [Full Text] [Related]  

  • 25. Magnetic resonance imaging applications in early rheumatoid arthritis diagnosis and management.
    Troum OM; Pimienta O; Olech E
    Rheum Dis Clin North Am; 2012 May; 38(2):277-97. PubMed ID: 22819084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synovial tissue analysis in clinical trials.
    Bresnihan B; Baeten D; Firestein GS; Fitzgerald OM; Gerlag DM; Haringman JJ; McInnes IB; Reece RJ; Smith MD; Ulfgren AK; Veale DJ; Tak PP;
    J Rheumatol; 2005 Dec; 32(12):2481-4. PubMed ID: 16331792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis.
    Isgren A; Forslind K; Erlandsson M; Axelsson C; Andersson S; Lund A; Bokarewa M
    Semin Arthritis Rheum; 2012 Apr; 41(5):652-7. PubMed ID: 22035627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Aletaha D; Smolen JS
    Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials.
    Boers M; Tugwell P; Felson DT; van Riel PL; Kirwan JR; Edmonds JP; Smolen JS; Khaltaev N; Muirden KD
    J Rheumatol Suppl; 1994 Sep; 41():86-9. PubMed ID: 7799394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greyscale and power Doppler ultrasonographic evaluation of normal synovial joints: correlation with pro- and anti-inflammatory cytokines and angiogenic factors.
    Kitchen J; Kane D
    Rheumatology (Oxford); 2015 Mar; 54(3):458-62. PubMed ID: 25193808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives.
    Chikanza IC; Kozaci DL
    Rheumatology (Oxford); 2004 Nov; 43(11):1337-45. PubMed ID: 15304669
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
    Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
    Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic factors in psoriatic arthritis].
    Fernández Sueiro JL; Lema Gontad JM
    Reumatol Clin; 2012 Mar; 8 Suppl 1():S7-9. PubMed ID: 22257679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weighting with the Lansbury articular index improves the correlation of ultrasound score with serum matrix metalloproteinase-3 level in rheumatoid arthritis patients.
    Gorai M; Ogasawara M; Matsuki Y; Yamada Y; Murayama G; Sugisaki N; Nemoto T; Ando S; Minowa K; Kon T; Tada K; Matsushita M; Yamaji K; Tamura N; Takasaki Y
    Mod Rheumatol; 2014 Nov; 24(6):915-9. PubMed ID: 24670135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint.
    Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
    Rheumatology (Oxford); 2013 Mar; 52(3):523-8. PubMed ID: 23192908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
    Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
    Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of ultrasound to assess the extent of inflammation in rheumatoid arthritis].
    Hammer HB
    Ultraschall Med; 2010 Aug; 31(4):437-8. PubMed ID: 20725899
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment Patterns of Multimorbid Patients with Rheumatoid Arthritis: Results from an International Cross-sectional Study.
    Radner H; Yoshida K; Hmamouchi I; Dougados M; Smolen JS; Solomon DH
    J Rheumatol; 2015 Jul; 42(7):1099-104. PubMed ID: 26034147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
    de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.